Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Dementia

parkinson's dementia1 - amyloid plaques13 - overweight people1 - postitron emission tomography1 - transdermal rivastigmine1 - hiv patients1 - fish oil supplements1 - thiamin deficiency1 - cognitive functioning2 - lack of concentration1 - igfbp-31 - exercise games1 - amyloid protein1 - mild alzheimer's disease1 - dysarthria1 - lafora1 - leg tremors1 - neuroanatomical changes1 - sunflower oil1 - sodium benzoate1 - developing alzheimer's disease1 - treat alzheimer's1 - protein tau2 - amyloid-beta plaque1 - physical reality1 - fronto temporal lobar degeneration1 - blood vessels1 - socioeconomic boundaries1 - alzheimer's disease biomarkers1 - cerebral haemorrhage1 -